{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:28:18Z","timestamp":1793644098644,"version":"4.5.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cientificas","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cognitive dysfunction in major depressive disorder (MDD) often persists despite standard treatment. Integral cognitive remediation (INCREM) shows clinical efficacy, yet its molecular drivers remain poorly understood compared to supportive interventions like psychoeducation (PSYCHOED). In this exploratory study, we investigated whether circulating microRNAs (miRNAs) reflect the distinct biological trajectories of these interventions. We conducted a longitudinal analysis of 38 candidate miRNAs (previously validated in postmortem brain tissue of MDD individuals) in plasma from 22 patients with MDD participating in a randomized clinical trial who were assigned to 12 weeks of INCREM or PSYCHOED. Using bioinformatic pathway analyses (KEGG\/GO), we identified non-overlapping miRNA profiles associated with each treatment. The INCREM response was characterized by a specific seven-miRNA signature (let-7b-3p, miR-100-5p, miR-129-5p, miR-135a-5p, miR-151a-5p, miR-4516, and miR-451a) targeting gene networks regulated in neuroplasticity, axon guidance, and synaptic transmission. These molecular changes mirrored significant objective cognitive improvements. Conversely, PSYCHOED induced a distinct profile (miR-126-5p and miR-195-5p) related to systemic cellular homeostasis and Wnt signaling, without objective cognitive gains. Our findings suggest that psychological therapies act as specific biological stimuli with distinct molecular targets. These circulating miRNA signatures provide preliminary evidence of neuroplasticity-related pathways as key drivers of cognitive recovery, offering potential blood-based biomarkers for precision psychiatry in MDD.<\/jats:p>","DOI":"10.1038\/s41598-026-55039-1","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:51:06Z","timestamp":1780069866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Peripheral miRNA profiling identifies therapy-specific biological trajectories in the treatment of cognitive dysfunction in depression: an exploratory mechanistic study"],"prefix":"10.1038","volume":"16","author":[{"given":"Lluis","family":"Miquel-Rio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Vicent-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Jeric\u00f3-Escolar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia","family":"Carrasco-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Jubero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonor","family":"Gawron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Ruiz-Bronchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javi","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"del Mar Bonn\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors","family":"Puigdemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Alemany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narc\u00eds","family":"Cardoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"de Diego-Adeli\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Analia","family":"Bortolozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Portella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"55039_CR1","doi-asserted-by":"crossref","unstructured":"GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 9, 137\u2013150 (2022).","DOI":"10.1016\/S2215-0366(21)00395-3"},{"key":"55039_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12991-025-00552-2","volume":"24","author":"M Vicent-Gil","year":"2025","unstructured":"Vicent-Gil, M. et al. Insights on the cognitive enhancement effect of desvenlafaxine in major depressive disorder. Ann. Gen. Psychiatry. 24, 16 (2025).","journal-title":"Ann. Gen. Psychiatry"},{"key":"55039_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/YCO.0000000000000378","volume":"31","author":"MJ Knight","year":"2018","unstructured":"Knight, M. J. & Baune, B. T. Cognitive dysfunction in major depressive disorder. Curr. Opin. Psychiatry. 31, 26\u201331 (2018).","journal-title":"Curr. Opin. Psychiatry"},{"key":"55039_CR4","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00406-022-01479-5","volume":"273","author":"D Kriesche","year":"2023","unstructured":"Kriesche, D., Woll, C. F. J., Tschentscher, N., Engel, R. R. & Karch, S. Neurocognitive deficits in depression: a systematic review of cognitive impairment in the acute and remitted state. Eur. Arch. Psychiatry Clin. Neurosci. 273, 1105\u20131128 (2023).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"55039_CR5","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1017\/S0033291712002085","volume":"43","author":"E Bora","year":"2013","unstructured":"Bora, E., Harrison, B. J., Y\u00fccel, M. & Pantelis, C. Cognitive impairment in euthymic major depressive disorder: a meta-analysis. Psychol. Med. 43, 2017\u20132026 (2013).","journal-title":"Psychol. Med."},{"key":"55039_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.comppsych.2014.08.051","volume":"56","author":"RS McIntyre","year":"2015","unstructured":"McIntyre, R. S. et al. The impact of cognitive impairment on perceived workforce performance: results from the International Mood Disorders Collaborative Project. Compr. Psychiatry. 56, 279\u2013282 (2015).","journal-title":"Compr. Psychiatry"},{"key":"55039_CR7","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1017\/S0033291713002535","volume":"44","author":"PL Rock","year":"2014","unstructured":"Rock, P. L., Roiser, J. P., Riedel, W. J. & Blackwell, A. D. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol. Med. 44, 2029\u20132040 (2014).","journal-title":"Psychol. Med."},{"key":"55039_CR8","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.4088\/JCP.13r08939","volume":"75","author":"VC Evans","year":"2014","unstructured":"Evans, V. C., Iverson, G. L., Yatham, L. N. & Lam, R. W. The relationship between neurocognitive and psychosocial functioning in major depressive disorder: a systematic review. J. Clin. Psychiatry. 75, 1359\u20131370 (2014).","journal-title":"J. Clin. Psychiatry"},{"key":"55039_CR9","doi-asserted-by":"publisher","first-page":"100572","DOI":"10.1016\/j.bpsgos.2025.100572","volume":"5","author":"S Vaishnavi","year":"2025","unstructured":"Vaishnavi, S. et al. Changes in Neural Activities and Neuroplasticity Related to Nonpharmacological Interventions for Major Depressive Disorder: A Systematic Literature Review. Biol. Psychiatry Glob Open. Sci. 5, 100572 (2025).","journal-title":"Biol. Psychiatry Glob Open. Sci."},{"key":"55039_CR10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41380-022-01806-1","volume":"28","author":"GR Fries","year":"2023","unstructured":"Fries, G. R., Saldana, V. A., Finnstein, J. & Rein, T. Molecular pathways of major depressive disorder converge on the synapse. Mol. Psychiatry. 28, 284\u2013297 (2023).","journal-title":"Mol. Psychiatry"},{"key":"55039_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41398-020-0825-7","volume":"10","author":"MR Al Shweiki","year":"2020","unstructured":"Al Shweiki, M. R. et al. Proteomic analysis reveals a biosignature of decreased synaptic protein in cerebrospinal fluid of major depressive disorder. Transl Psychiatry. 10, 144 (2020).","journal-title":"Transl Psychiatry"},{"key":"55039_CR12","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41467-019-09562-7","volume":"10","author":"SE Holmes","year":"2019","unstructured":"Holmes, S. E. et al. Lower synaptic density is associated with depression severity and network alterations. Nat. Commun. 10, 1529 (2019).","journal-title":"Nat. Commun."},{"key":"55039_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/bs.pbr.2025.05.007","volume":"295","author":"M Hanampa-Maquera","year":"2025","unstructured":"Hanampa-Maquera, M., Louren\u00e7o, R. C., Bailey, A. & Camarini, R. Hormetic pathways in environmental enrichment in animal models and humans. Prog Brain Res. 295, 189\u2013227 (2025).","journal-title":"Prog Brain Res."},{"key":"55039_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41386-022-01370-w","volume":"48","author":"LG Appelbaum","year":"2023","unstructured":"Appelbaum, L. G., Shenasa, M. A., Stolz, L. & Daskalakis, Z. Synaptic plasticity and mental health: methods, challenges and opportunities. Neuropsychopharmacology 48, 113\u2013120 (2023).","journal-title":"Neuropsychopharmacology"},{"key":"55039_CR15","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/glia.23593","volume":"67","author":"MN Fullana","year":"2019","unstructured":"Fullana, M. N. et al. Regionally selective knockdown of astroglial glutamate transporters in infralimbic cortex induces a depressive phenotype in mice. Glia 67, 1122\u20131137 (2019).","journal-title":"Glia"},{"key":"55039_CR16","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/nm.2886","volume":"18","author":"HJ Kang","year":"2012","unstructured":"Kang, H. J. et al. Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat. Med. 18, 1413\u20131417 (2012).","journal-title":"Nat. Med."},{"key":"55039_CR17","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1038\/s41467-021-21943-5","volume":"12","author":"J Li","year":"2021","unstructured":"Li, J. et al. Cortical structural differences in major depressive disorder correlate with cell type-specific transcriptional signatures. Nat. Commun. 12, 1647 (2021).","journal-title":"Nat. Commun."},{"key":"55039_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41398-020-0842-6","volume":"10","author":"L Schmaal","year":"2020","unstructured":"Schmaal, L. et al. ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing. Transl Psychiatry. 10, 172 (2020).","journal-title":"Transl Psychiatry"},{"key":"55039_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1176\/appi.ajp.2016.16050518","volume":"174","author":"BW Dunlop","year":"2017","unstructured":"Dunlop, B. W. et al. Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder. Am. J. Psychiatry. 174, 533\u2013545 (2017).","journal-title":"Am. J. Psychiatry"},{"key":"55039_CR20","doi-asserted-by":"publisher","first-page":"e79055","DOI":"10.1371\/journal.pone.0079055","volume":"9","author":"L Kong","year":"2014","unstructured":"Kong, L. et al. Frontal-subcortical volumetric deficits in single episode, medication-na\u00efve depressed patients and the effects of 8 weeks fluoxetine treatment: a VBM-DARTEL study. PloS One. 9, e79055 (2014).","journal-title":"PloS One"},{"key":"55039_CR21","doi-asserted-by":"crossref","unstructured":"Kotoula, V., Evans, J. W., Punturieri, C. E., Zarate, C. A. & Review The use of functional magnetic resonance imaging (fMRI) in clinical trials and experimental research studies for depression. Front. Neuroimaging 2 (2023).","DOI":"10.3389\/fnimg.2023.1110258"},{"key":"55039_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.biopsych.2021.11.016","volume":"92","author":"AM Leaver","year":"2022","unstructured":"Leaver, A. M., Espinoza, R., Wade, B. & Narr, K. L. Parsing the Network Mechanisms of Electroconvulsive Therapy. Biol. Psychiatry. 92, 193\u2013203 (2022).","journal-title":"Biol. Psychiatry"},{"key":"55039_CR23","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jad.2012.07.029","volume":"146","author":"R Smith","year":"2013","unstructured":"Smith, R., Chen, K., Baxter, L., Fort, C. & Lane, R. D. Antidepressant effects of sertraline associated with volume increases in dorsolateral prefrontal cortex. J. Affect. Disord. 146, 414\u2013419 (2013).","journal-title":"J. Affect. Disord"},{"key":"55039_CR24","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.jad.2016.10.017","volume":"208","author":"S Yoshimura","year":"2017","unstructured":"Yoshimura, S. et al. Cognitive behavioral therapy changes functional connectivity between medial prefrontal and anterior cingulate cortices. J. Affect. Disord. 208, 610\u2013614 (2017).","journal-title":"J. Affect. Disord"},{"key":"55039_CR25","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41386-020-00861-y","volume":"46","author":"Y Yoshino","year":"2021","unstructured":"Yoshino, Y., Roy, B. & Dwivedi, Y. Differential and unique patterns of synaptic miRNA expression in dorsolateral prefrontal cortex of depressed subjects. Neuropsychopharmacol. Off Publ Am. Coll. Neuropsychopharmacol. 46, 900\u2013910 (2021).","journal-title":"Neuropsychopharmacol. Off Publ Am. Coll. Neuropsychopharmacol."},{"key":"55039_CR26","doi-asserted-by":"publisher","first-page":"e70135","DOI":"10.1002\/ctm2.70135","volume":"15","author":"B Roy","year":"2025","unstructured":"Roy, B., Verma, A. K., Funahashi, Y. & Dwivedi, Y. Deciphering the epigenetic role of long non-coding RNAs in mood disorders: Focus on human brain studies. Clin. Transl Med. 15, e70135 (2025).","journal-title":"Clin. Transl Med."},{"key":"55039_CR27","doi-asserted-by":"publisher","first-page":"11312","DOI":"10.3390\/ijms222111312","volume":"22","author":"D \u017burawek","year":"2021","unstructured":"\u017burawek, D. & Turecki, G. The miRNome of Depression. Int. J. Mol. Sci. 22, 11312 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"55039_CR28","doi-asserted-by":"publisher","first-page":"107873","DOI":"10.1016\/j.pharmthera.2021.107873","volume":"227","author":"A Bortolozzi","year":"2021","unstructured":"Bortolozzi, A., Manashirov, S., Chen, A. & Artigas, F. Oligonucleotides as therapeutic tools for brain disorders: Focus on major depressive disorder and Parkinson\u2019s disease. Pharmacol. Ther. 227, 107873 (2021).","journal-title":"Pharmacol. Ther."},{"key":"55039_CR29","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1038\/s41380-020-00953-7","volume":"26","author":"LM Fiori","year":"2021","unstructured":"Fiori, L. M. et al. miR-323a regulates ERBB4 and is involved in depression. Mol. Psychiatry. 26, 4191\u20134204 (2021).","journal-title":"Mol. Psychiatry"},{"key":"55039_CR30","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1126\/science.1193692","volume":"329","author":"A Baudry","year":"2010","unstructured":"Baudry, A., Mouillet-Richard, S., Schneider, B., Launay, J. M. & Kellermann, O. MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants. Science 329, 1537\u20131541 (2010).","journal-title":"Science"},{"key":"55039_CR31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.neuron.2014.05.042","volume":"83","author":"O Issler","year":"2014","unstructured":"Issler, O. et al. MicroRNA 135 is essential for chronic stress resiliency, antidepressant efficacy, and intact serotonergic activity. Neuron 83, 344\u2013360 (2014).","journal-title":"Neuron"},{"key":"55039_CR32","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s12017-014-8312-z","volume":"16","author":"X Yang","year":"2014","unstructured":"Yang, X. et al. MicroRNA Expression Profile and Functional Analysis Reveal that miR-206 is a Critical Novel Gene for the Expression of BDNF Induced by Ketamine. NeuroMolecular Med. 16, 594\u2013605 (2014).","journal-title":"NeuroMolecular Med."},{"key":"55039_CR33","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nm.3582","volume":"20","author":"JP Lopez","year":"2014","unstructured":"Lopez, J. P. et al. miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment. Nat. Med. 20, 764\u2013768 (2014).","journal-title":"Nat. Med."},{"key":"55039_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jpsychires.2016.07.012","volume":"82","author":"JA Azevedo","year":"2016","unstructured":"Azevedo, J. A. et al. The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression. J. Psychiatr Res. 82, 58\u201367 (2016).","journal-title":"J. Psychiatr Res."},{"key":"55039_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40035-024-00418-9","volume":"13","author":"RDC Bravo-Miana","year":"2024","unstructured":"Bravo-Miana, R. D. C., Arizaga-Echebarria, J. K. & Otaegui, D. Central nervous system-derived extracellular vesicles: the next generation of neural circulating biomarkers? Transl Neurodegener. 13, 32 (2024).","journal-title":"Transl Neurodegener"},{"key":"55039_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.euroneuro.2024.12.011","volume":"93","author":"L Miquel-Rio","year":"2025","unstructured":"Miquel-Rio, L., Anmella, G. & Bortolozzi, A. MiRNAs and extracellular vesicles in psychiatry: Potential biomarkers, therapeutic advances, and animal models. Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol. 93, 3\u20134 (2025).","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"55039_CR37","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.ymthe.2023.02.013","volume":"31","author":"J R\u00e4dler","year":"2023","unstructured":"R\u00e4dler, J., Gupta, D., Zickler, A. & Andaloussi, S. E. Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading. Mol. Ther. 31, 1231\u20131250 (2023).","journal-title":"Mol. Ther."},{"key":"55039_CR38","doi-asserted-by":"publisher","first-page":"7417","DOI":"10.1038\/s41380-021-01255-2","volume":"26","author":"S Saeedi","year":"2021","unstructured":"Saeedi, S. et al. Neuron-derived extracellular vesicles enriched from plasma show altered size and miRNA cargo as a function of antidepressant drug response. Mol. Psychiatry. 26, 7417\u20137424 (2021).","journal-title":"Mol. Psychiatry"},{"key":"55039_CR39","doi-asserted-by":"publisher","first-page":"101108","DOI":"10.1016\/j.bbih.2025.101108","volume":"49","author":"K Johannessen","year":"2025","unstructured":"Johannessen, K. et al. Dysregulated miR-1246 and miR-1253 link inflammatory protein markers in plasma to major depressive disorder in female adolescents. Brain Behav. Immun. - Health. 49, 101108 (2025).","journal-title":"Brain Behav. Immun. - Health"},{"key":"55039_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-025-03102-0","author":"W Liang","year":"2025","unstructured":"Liang, W. et al. Alterations in miR-151a-3p of plasma-derived exosomes and associated multimodal neuroimaging patterns in major depressive disorder. Mol. Psychiatry. https:\/\/doi.org\/10.1038\/s41380-025-03102-0 (2025).","journal-title":"Mol. Psychiatry"},{"key":"55039_CR41","doi-asserted-by":"crossref","unstructured":"Gecys, D. et al. Circulating hsa-let-7e-5p and hsa-miR-125a-5p as possible biomarkers in the diagnosis of major depression and bipolar disorders. Dis. Markers 2022, 3004338 (2022).","DOI":"10.1155\/2022\/3004338"},{"key":"55039_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jad.2022.05.016","volume":"310","author":"M Vicent-Gil","year":"2022","unstructured":"Vicent-Gil, M. et al. Randomized clinical trial of integral cognitive remediation program for major depression (INCREM). J. Affect. Disord. 310, 189\u2013197 (2022).","journal-title":"J. Affect. Disord"},{"key":"55039_CR43","doi-asserted-by":"publisher","first-page":"104569","DOI":"10.1016\/j.nsa.2024.104569","volume":"3","author":"LM Rio","year":"2024","unstructured":"Rio, L. M. et al. miRNA-seq analyses in human dorsolateral prefrontal cortex reveal sex-specific differences in miRNAs regulating depression and suicide-related pathways. Neurosci. Appl. 3, 104569 (2024).","journal-title":"Neurosci. Appl."},{"key":"55039_CR44","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12974-025-03608-y","volume":"22","author":"L Miquel-Rio","year":"2025","unstructured":"Miquel-Rio, L. et al. A molecular convergence in the triad of parkinson\u2019s disease, depressive disorder and gut health is revealed by the inflammation-miRNA axis. J. Neuroinflammation. 22, 260 (2025).","journal-title":"J. Neuroinflammation"},{"key":"55039_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12888-019-2117-4","volume":"19","author":"M Vicent-Gil","year":"2019","unstructured":"Vicent-Gil, M. et al. Testing the efficacy of INtegral Cognitive REMediation (INCREM) in major depressive disorder: study protocol for a randomized clinical trial. BMC Psychiatry. 19, 135 (2019).","journal-title":"BMC Psychiatry"},{"key":"55039_CR46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton, M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23, 56\u201362 (1960).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"55039_CR47","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0025-7753(03)73814-7","volume":"120","author":"J Bobes","year":"2003","unstructured":"Bobes, J. et al. [A comparative psychometric study of the Spanish versions with 6, 17, and 21 items of the Hamilton Depression Rating Scale]. Med. Clin. (Barc). 120, 693\u2013700 (2003).","journal-title":"Med. Clin. (Barc)"},{"key":"55039_CR48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.7224\/1537-2073.2015-028","volume":"18","author":"LB Strober","year":"2016","unstructured":"Strober, L. B., Binder, A., Nikelshpur, O. M., Chiaravalloti, N. & DeLuca, J. The Perceived Deficits Questionnaire: Perception, Deficit, or Distress? Int. J. MS Care. 18, 183\u2013190 (2016).","journal-title":"Int. J. MS Care"},{"key":"55039_CR49","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.2147\/NDT.S175188","volume":"14","author":"RW Lam","year":"2018","unstructured":"Lam, R. W. et al. Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder. Neuropsychiatr Dis. Treat. 14, 2861\u20132877 (2018).","journal-title":"Neuropsychiatr Dis. Treat."},{"key":"55039_CR50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1745-0179-3-5","volume":"3","author":"AR Rosa","year":"2007","unstructured":"Rosa, A. R. et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin. Pract. Epidemiol. Ment Health CP EMH. 3, 5 (2007).","journal-title":"Clin. Pract. Epidemiol. Ment Health CP EMH"},{"key":"55039_CR51","doi-asserted-by":"crossref","unstructured":"Wechsler, D. Wechsler Adult Intelligence Scale: WAIS-IV; Technical and Interpretive Manual (Pearson Assessment, 2008).","DOI":"10.1037\/t15169-000"},{"issue":"Suppl 16","key":"55039_CR52","first-page":"10","volume":"62","author":"HA Sackeim","year":"2001","unstructured":"Sackeim, H. A. The definition and meaning of treatment-resistant depression. J. Clin. Psychiatry. 62(Suppl 16), 10\u201317 (2001).","journal-title":"J. Clin. Psychiatry"},{"key":"55039_CR53","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"55039_CR54","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. Publ Protein Soc. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci. Publ Protein Soc."},{"key":"55039_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"55039_CR56","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1038\/s41380-025-02945-x","volume":"30","author":"YI Sheline","year":"2025","unstructured":"Sheline, Y. I. et al. Neuroimaging changes in major depression with brief computer-assisted cognitive behavioral therapy compared to waitlist. Mol. Psychiatry. 30, 3579\u20133587 (2025).","journal-title":"Mol. Psychiatry"},{"key":"55039_CR57","doi-asserted-by":"publisher","first-page":"pyae013","DOI":"10.1093\/ijnp\/pyae013","volume":"27","author":"P Ibrahim","year":"2024","unstructured":"Ibrahim, P. et al. Profiling Small RNA From Brain Extracellular Vesicles in Individuals With Depression. Int. J. Neuropsychopharmacol. 27, pyae013 (2024).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"55039_CR58","doi-asserted-by":"publisher","first-page":"549","DOI":"10.4306\/pi.2016.13.5.549","volume":"13","author":"VR Enatescu","year":"2016","unstructured":"Enatescu, V. R. et al. Circulating Plasma Micro RNAs in Patients with Major Depressive Disorder Treated with Antidepressants: A Pilot Study. Psychiatry Investig. 13, 549\u2013557 (2016).","journal-title":"Psychiatry Investig"},{"key":"55039_CR59","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1007\/s00221-021-06203-8","volume":"239","author":"J Chang","year":"2021","unstructured":"Chang, J., Zhang, Y., Shen, N., Zhou, J. & Zhang, H. MiR-129-5p prevents depressive-like behaviors by targeting MAPK1 to suppress inflammation. Exp. Brain Res. 239, 3359\u20133370 (2021).","journal-title":"Exp. Brain Res."},{"key":"55039_CR60","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.euroneuro.2018.01.005","volume":"28","author":"F Artigas","year":"2018","unstructured":"Artigas, F., Celada, P. & Bortolozzi, A. Can we increase the speed and efficacy of antidepressant treatments? Part II. Glutamatergic and RNA interference strategies. Eur. Neuropsychopharmacol. 28, 457\u2013482 (2018).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"55039_CR61","first-page":"69","volume":"23","author":"A Gheysarzadeh","year":"2018","unstructured":"Gheysarzadeh, A. et al. Serum-based microRNA biomarkers for major depression: MiR-16, miR-135a, and miR-1202. J. Res. Med. Sci. Off J. Isfahan Univ. Med. Sci. 23, 69 (2018).","journal-title":"J. Res. Med. Sci. Off J. Isfahan Univ. Med. Sci."},{"key":"55039_CR62","doi-asserted-by":"publisher","first-page":"e682","DOI":"10.1038\/tp.2015.175","volume":"5","author":"Y Dwivedi","year":"2015","unstructured":"Dwivedi, Y. et al. Chronic corticosterone-mediated dysregulation of microRNA network in prefrontal cortex of rats: relevance to depression pathophysiology. Transl Psychiatry. 5, e682 (2015).","journal-title":"Transl Psychiatry"},{"key":"55039_CR63","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/ijnp\/pyx034","volume":"20","author":"LM Fiori","year":"2017","unstructured":"Fiori, L. M. et al. Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response. Int. J. Neuropsychopharmacol. 20, 619\u2013623 (2017).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"55039_CR64","doi-asserted-by":"publisher","first-page":"109867","DOI":"10.1016\/j.pnpbp.2020.109867","volume":"100","author":"VS Marshe","year":"2020","unstructured":"Marshe, V. S. et al. Validation study of microRNAs previously associated with antidepressant response in older adults treated for late-life depression with venlafaxine. Prog Neuropsychopharmacol. Biol. Psychiatry. 100, 109867 (2020).","journal-title":"Prog Neuropsychopharmacol. Biol. Psychiatry"},{"key":"55039_CR65","doi-asserted-by":"publisher","first-page":"e7212","DOI":"10.1590\/1414-431x20187212","volume":"51","author":"WH Kuang","year":"2018","unstructured":"Kuang, W. H., Dong, Z. Q., Tian, L. T. & Li, J. MicroRNA-451a, microRNA-34a-5p, and microRNA-221-3p as predictors of response to antidepressant treatment. Braz J. Med. Biol. Res. Rev. Bras. Pesqui Medicas E Biol. 51, e7212 (2018).","journal-title":"Braz J. Med. Biol. Res. Rev. Bras. Pesqui Medicas E Biol."},{"key":"55039_CR66","doi-asserted-by":"publisher","first-page":"e0121975","DOI":"10.1371\/journal.pone.0121975","volume":"10","author":"Y Wan","year":"2015","unstructured":"Wan, Y. et al. Identification of differential microRNAs in cerebrospinal fluid and serum of patients with major depressive disorder. PloS One. 10, e0121975 (2015).","journal-title":"PloS One"},{"key":"55039_CR67","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jpsychires.2015.07.023","volume":"69","author":"MA Camkurt","year":"2015","unstructured":"Camkurt, M. A. et al. Comparison of plasma MicroRNA levels in drug naive, first episode depressed patients and healthy controls. J. Psychiatr Res. 69, 67\u201371 (2015).","journal-title":"J. Psychiatr Res."},{"key":"55039_CR68","doi-asserted-by":"publisher","first-page":"e101291","DOI":"10.1136\/gpsych-2023-101291","volume":"37","author":"P Hu","year":"2024","unstructured":"Hu, P. et al. MicroRNA-451a is a candidate biomarker and therapeutic target for major depressive disorder. Gen. Psychiatry. 37, e101291 (2024).","journal-title":"Gen. Psychiatry"},{"key":"55039_CR69","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.7150\/thno.81826","volume":"13","author":"H Feng","year":"2023","unstructured":"Feng, H. et al. Decreased miR-451a in cerebrospinal fluid, a marker for both cognitive impairment and depressive symptoms in Alzheimer\u2019s disease. Theranostics 13, 3021\u20133040 (2023).","journal-title":"Theranostics"},{"key":"55039_CR70","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/genes13040562","volume":"13","author":"A Videti\u010d Paska","year":"2022","unstructured":"Videti\u010d Paska, A., Ali\u010d, U., Zupanc, T. & Kouter, K. Suicide and Changes in Expression of Neuronal miRNA Predicted by an Algorithm Search through miRNA Databases. Genes 13, 562 (2022).","journal-title":"Genes"},{"key":"55039_CR71","doi-asserted-by":"publisher","first-page":"e12868","DOI":"10.1111\/gbb.12868","volume":"22","author":"I \u0160alamon Ar\u010dan","year":"2023","unstructured":"\u0160alamon Ar\u010dan, I., Katra\u0161nik, M., Kouter, K. & Zupanc, T. Videti\u010d Paska, A. Extracellular vesicles from cerebrospinal fluid revealed changes in miR-19a-3p and miR-4516 expression in Slovene male suicides. Genes Brain Behav. 22, e12868 (2023).","journal-title":"Genes Brain Behav."},{"key":"55039_CR72","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nn.2270","volume":"12","author":"PO McGowan","year":"2009","unstructured":"McGowan, P. O. et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 12, 342\u2013348 (2009).","journal-title":"Nat. Neurosci."},{"key":"55039_CR73","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41398-023-02326-4","volume":"13","author":"J Honorato-Mauer","year":"2023","unstructured":"Honorato-Mauer, J. et al. Alterations in microRNA of extracellular vesicles associated with major depression, attention-deficit\/hyperactivity and anxiety disorders in adolescents. Transl Psychiatry. 13, 47 (2023).","journal-title":"Transl Psychiatry"},{"key":"55039_CR74","doi-asserted-by":"publisher","first-page":"e504","DOI":"10.1038\/tp.2014.139","volume":"5","author":"JG Hunsberger","year":"2015","unstructured":"Hunsberger, J. G. et al. Novel integrative genomic tool for interrogating lithium response in bipolar disorder. Transl Psychiatry. 5, e504 (2015).","journal-title":"Transl Psychiatry"},{"key":"55039_CR75","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1124\/pharmrev.120.000007","volume":"76","author":"A Bortolozzi","year":"2024","unstructured":"Bortolozzi, A. et al. New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview. Pharmacol. Rev. 76, 323\u2013357 (2024).","journal-title":"Pharmacol. Rev."},{"key":"55039_CR76","doi-asserted-by":"publisher","first-page":"31729","DOI":"10.1038\/s41598-024-81921-x","volume":"14","author":"W Wang","year":"2024","unstructured":"Wang, W. et al. Increased expression of plasma mir-9-3p and let-7b-3p in methamphetamine use disorder and its clinical significance. Sci. Rep. 14, 31729 (2024).","journal-title":"Sci. Rep."},{"key":"55039_CR77","doi-asserted-by":"publisher","first-page":"8952","DOI":"10.3390\/ijms25168952","volume":"25","author":"W Li","year":"2024","unstructured":"Li, W. et al. Combined Diagnostic Value of Hsa-miR-592 and Hsa-miR-9-3p in Plasma for Methamphetamine Addicts. Int. J. Mol. Sci. 25, 8952 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"55039_CR78","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s13277-015-3267-8","volume":"36","author":"C Qin","year":"2015","unstructured":"Qin, C., Huang, R. Y. & Wang, Z. X. Potential role of miR-100 in cancer diagnosis, prognosis, and therapy. Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med. 36, 1403\u20131409 (2015).","journal-title":"Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med."},{"key":"55039_CR79","doi-asserted-by":"crossref","unstructured":"Ge, Y. et al. miR-100 suppresses the proliferation, invasion, and migration of hepatocellular carcinoma cells via targeting CXCR7. J. Immunol. Res. 2021, 9920786 (2021).","DOI":"10.1155\/2021\/9920786"},{"key":"55039_CR80","doi-asserted-by":"publisher","first-page":"e36265","DOI":"10.1097\/MD.0000000000036265","volume":"102","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Screening and identification of key biomarkers associated with amyotrophic lateral sclerosis and depression using bioinformatics. Med. (Baltim). 102, e36265 (2023).","journal-title":"Med. (Baltim)."},{"key":"55039_CR81","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1126\/science.1067020","volume":"294","author":"ER Kandel","year":"2001","unstructured":"Kandel, E. R. The molecular biology of memory storage: a dialogue between genes and synapses. Science 294, 1030\u20131038 (2001).","journal-title":"Science"},{"key":"55039_CR82","doi-asserted-by":"publisher","first-page":"a001842","DOI":"10.1101\/cshperspect.a001842","volume":"2","author":"K Shen","year":"2010","unstructured":"Shen, K. & Cowan, C. W. Guidance molecules in synapse formation and plasticity. Cold Spring Harb Perspect. Biol. 2, a001842 (2010).","journal-title":"Cold Spring Harb Perspect. Biol."},{"key":"55039_CR83","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1176\/appi.ajp.2010.10060855","volume":"168","author":"T Wykes","year":"2011","unstructured":"Wykes, T., Huddy, V., Cellard, C., McGurk, S. R. & Czobor, P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am. J. Psychiatry. 168, 472\u2013485 (2011).","journal-title":"Am. J. Psychiatry"},{"key":"55039_CR84","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.biopsych.2013.01.017","volume":"73","author":"R Penad\u00e9s","year":"2013","unstructured":"Penad\u00e9s, R. et al. Brain effects of cognitive remediation therapy in schizophrenia: a structural and functional neuroimaging study. Biol. Psychiatry. 73, 1015\u20131023 (2013).","journal-title":"Biol. Psychiatry"},{"key":"55039_CR85","first-page":"652","volume":"20","author":"MW Cole","year":"2014","unstructured":"Cole, M. W., Repov\u0161, G. & Anticevic, A. The frontoparietal control system: a central role in mental health. Neurosci. Rev. J. Bringing Neurobiol. Neurol. Psychiatry. 20, 652\u2013664 (2014).","journal-title":"Neurosci. Rev. J. Bringing Neurobiol. Neurol. Psychiatry"},{"key":"55039_CR86","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/CAD.0000000000001084","volume":"32","author":"L Yang","year":"2021","unstructured":"Yang, L., Bi, T., Zhou, S., Lan, Y. & Zhang, R. CircRASSF2 facilitates the proliferation and metastasis of colorectal cancer by mediating the activity of Wnt\/\u03b2-catenin signaling pathway by regulating the miR-195-5p\/FZD4 axis. Anticancer Drugs. 32, 919\u2013929 (2021).","journal-title":"Anticancer Drugs"},{"key":"55039_CR87","doi-asserted-by":"publisher","first-page":"893","DOI":"10.21037\/atm-22-3685","volume":"10","author":"H Zhu","year":"2022","unstructured":"Zhu, H. et al. MiR-195-5p suppresses the proliferation, migration, and invasion of gallbladder cancer cells by targeting FOSL1 and regulating the Wnt\/\u03b2-catenin pathway. Ann. Transl Med. 10, 893 (2022).","journal-title":"Ann. Transl Med."},{"key":"55039_CR88","doi-asserted-by":"publisher","first-page":"106970","DOI":"10.1016\/j.intimp.2020.106970","volume":"88","author":"Y Tian","year":"2020","unstructured":"Tian, Y. et al. LncRNA CDKN2B-AS1 relieved inflammation of ulcerative colitis via sponging miR-16 and miR-195. Int. Immunopharmacol. 88, 106970 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"55039_CR89","first-page":"559","volume":"69","author":"HR Wang","year":"2020","unstructured":"Wang, H. R., Guo, X. Y., Liu, X. Y. & Song, X. Down-regulation of lncRNA CASC9 aggravates sepsis-induced acute lung injury by regulating miR-195-5p\/PDK4 axis. Inflamm. Res. Off J. Eur. Histamine Res. Soc. Al. 69, 559\u2013568 (2020).","journal-title":"Inflamm. Res. Off J. Eur. Histamine Res. Soc. Al"},{"key":"55039_CR90","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0000000000001100","author":"C Galbiati","year":"2025","unstructured":"Galbiati, C. et al. Plasma microRNA Levels After Electroconvulsive Therapy in Treatment-Resistant Depressed Patients. J. ECT. https:\/\/doi.org\/10.1097\/YCT.0000000000001100 (2025).","journal-title":"J. ECT"},{"key":"55039_CR91","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.1007\/s12035-016-0107-9","volume":"54","author":"D Zurawek","year":"2017","unstructured":"Zurawek, D. et al. Reciprocal MicroRNA Expression in Mesocortical Circuit and Its Interplay with Serotonin Transporter Define Resilient Rats in the Chronic Mild Stress. Mol. Neurobiol. 54, 5741\u20135751 (2017).","journal-title":"Mol. Neurobiol."},{"key":"55039_CR92","doi-asserted-by":"publisher","first-page":"110993","DOI":"10.1016\/j.ygeno.2025.110993","volume":"117","author":"Y Xu","year":"2025","unstructured":"Xu, Y. et al. Identification of aberrant plasma vesicles containing AAK1 and CCDC18-AS1 in adolescents with major depressive disorder and preliminary exploration of treatment efficacy. Genomics 117, 110993 (2025).","journal-title":"Genomics"},{"key":"55039_CR93","first-page":"e2105442","volume":"9","author":"Z Yu","year":"2022","unstructured":"Yu, Z. et al. Microglia Regulate Blood-Brain Barrier Integrity via MiR-126a-5p\/MMP9 Axis during Inflammatory Demyelination. Adv. Sci. Weinh Baden-Wurtt Ger. 9, e2105442 (2022).","journal-title":"Adv. Sci. Weinh Baden-Wurtt Ger."},{"key":"55039_CR94","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1161\/STROKEAHA.119.027531","volume":"51","author":"J Pan","year":"2020","unstructured":"Pan, J. et al. MicroRNA-126-3p\/-5p Overexpression Attenuates Blood-Brain Barrier Disruption in a Mouse Model of Middle Cerebral Artery Occlusion. Stroke 51, 619\u2013627 (2020).","journal-title":"Stroke"},{"key":"55039_CR95","doi-asserted-by":"publisher","first-page":"102864","DOI":"10.1016\/j.nicl.2021.102864","volume":"32","author":"PL Ballester","year":"2021","unstructured":"Ballester, P. L. et al. Accelerated brain aging in major depressive disorder and antidepressant treatment response: A CAN-BIND report. NeuroImage Clin. 32, 102864 (2021).","journal-title":"NeuroImage Clin."},{"key":"55039_CR96","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/mp.2013.151","volume":"19","author":"JE Verhoeven","year":"2014","unstructured":"Verhoeven, J. E. et al. Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study. Mol. Psychiatry. 19, 895\u2013901 (2014).","journal-title":"Mol. Psychiatry"},{"key":"55039_CR97","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","volume":"107","author":"E Beurel","year":"2020","unstructured":"Beurel, E., Toups, M. & Nemeroff, C. B. The Bidirectional Relationship of Depression and Inflammation: Double Trouble. Neuron 107, 234\u2013256 (2020).","journal-title":"Neuron"},{"key":"55039_CR98","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/978-981-33-6044-0_27","volume":"1305","author":"C Jones","year":"2021","unstructured":"Jones, C. & Nemeroff, C. B. Precision Psychiatry: Biomarker-Guided Tailored Therapy for Effective Treatment and Prevention in Major Depression. Adv. Exp. Med. Biol. 1305, 535\u2013563 (2021).","journal-title":"Adv. Exp. Med. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55039-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55039-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55039-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:02:41Z","timestamp":1786323761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55039-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55039"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55039-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the national ethical standards and norms and with the 1964 Helsinki Declaration by its later amendments (version of Fortaleza, 2013). Ethical approval was obtained from the local ethics committee of Hospital de la Santa Creu i Sant Pau (CEIm Sant Pau; ref. 21\/119). All participants provided written informed consent prior to their inclusion in the study.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All co-authors approve for the publication of the study.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24649"}}